Review



vb bcem ap3 0015  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC vb bcem ap3 0015
    Vb Bcem Ap3 0015, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vb bcem ap3 0015/product/ATCC
    Average 95 stars, based on 130 article reviews
    vb bcem ap3 0015 - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    95
    ATCC vb bcem ap3 0015
    Vb Bcem Ap3 0015, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vb bcem ap3 0015/product/ATCC
    Average 95 stars, based on 1 article reviews
    vb bcem ap3 0015 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    Malvern Panalytical ap3
    Ap3, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ap3/product/Malvern Panalytical
    Average 99 stars, based on 1 article reviews
    ap3 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    93
    Biorbyt perk
    Perk, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/perk/product/Biorbyt
    Average 93 stars, based on 1 article reviews
    perk - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Decon Laboratories ap3 lamp1 merge inset
    Ap3 Lamp1 Merge Inset, supplied by Decon Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ap3 lamp1 merge inset/product/Decon Laboratories
    Average 90 stars, based on 1 article reviews
    ap3 lamp1 merge inset - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology anti dap3 antibody
    <t>DAP3</t> expression was related with poor prognosis in public datasets: (A) Relative DAP3 expression levels across TCGA, GEO, and ICGC datasets. (B) Survival curves derived from TCGA datasets. (C) Survival curves based on ICGC datasets. (D) Univariate Cox regression analysis for overall survival in HCC. (E) Multivariate Cox regression analysis related to overall survival in HCC. (F) DAP3 expression in various pan-cancers using TIMER2.0 datasets. (G) DAP3 expression in various HCC subtypes using UALCAN datasets. (H) Overall survival analysis across pan-cancers. (I) Survival curves in CESC, KIRC, and KIRP. *P<0.05, **P<0.01, ***P<0.001, ****P < 0.0001.
    Anti Dap3 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti dap3 antibody/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    anti dap3 antibody - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    95
    ATCC burkholderia phage ap3
    Comparison of the selected phage endolysins.
    Burkholderia Phage Ap3, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/burkholderia phage ap3/product/ATCC
    Average 95 stars, based on 1 article reviews
    burkholderia phage ap3 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    NETGEAR Inc nighthawk x4 r7500 ac2350 access points ap3
    Comparison of the selected phage endolysins.
    Nighthawk X4 R7500 Ac2350 Access Points Ap3, supplied by NETGEAR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nighthawk x4 r7500 ac2350 access points ap3/product/NETGEAR Inc
    Average 90 stars, based on 1 article reviews
    nighthawk x4 r7500 ac2350 access points ap3 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Medicago ap3-like genes
    Comparison of the selected phage endolysins.
    Ap3 Like Genes, supplied by Medicago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ap3-like genes/product/Medicago
    Average 90 stars, based on 1 article reviews
    ap3-like genes - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Varex Imaging imaging xrd 1642 ap3 fpd
    Comparison of the selected phage endolysins.
    Imaging Xrd 1642 Ap3 Fpd, supplied by Varex Imaging, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/imaging xrd 1642 ap3 fpd/product/Varex Imaging
    Average 90 stars, based on 1 article reviews
    imaging xrd 1642 ap3 fpd - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Absolute Biotech Inc ap3
    Comparison of the selected phage endolysins.
    Ap3, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ap3/product/Absolute Biotech Inc
    Average 90 stars, based on 1 article reviews
    ap3 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    DAP3 expression was related with poor prognosis in public datasets: (A) Relative DAP3 expression levels across TCGA, GEO, and ICGC datasets. (B) Survival curves derived from TCGA datasets. (C) Survival curves based on ICGC datasets. (D) Univariate Cox regression analysis for overall survival in HCC. (E) Multivariate Cox regression analysis related to overall survival in HCC. (F) DAP3 expression in various pan-cancers using TIMER2.0 datasets. (G) DAP3 expression in various HCC subtypes using UALCAN datasets. (H) Overall survival analysis across pan-cancers. (I) Survival curves in CESC, KIRC, and KIRP. *P<0.05, **P<0.01, ***P<0.001, ****P < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: DAP3 expression was related with poor prognosis in public datasets: (A) Relative DAP3 expression levels across TCGA, GEO, and ICGC datasets. (B) Survival curves derived from TCGA datasets. (C) Survival curves based on ICGC datasets. (D) Univariate Cox regression analysis for overall survival in HCC. (E) Multivariate Cox regression analysis related to overall survival in HCC. (F) DAP3 expression in various pan-cancers using TIMER2.0 datasets. (G) DAP3 expression in various HCC subtypes using UALCAN datasets. (H) Overall survival analysis across pan-cancers. (I) Survival curves in CESC, KIRC, and KIRP. *P<0.05, **P<0.01, ***P<0.001, ****P < 0.0001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing, Derivative Assay

    Correlation between DAP3 and immune-related functions in HCC: (A) Immune cell infiltration in low and high DAP3 expression groups based on TIMER scores. (B) Immune cell infiltration in low and high DAP3 expression groups based on CIBERSORT scores. (C) Immune cell infiltration in low and high DAP3 expression groups based on MCP-counter scores. (D) Proportional plot illustrating the relationship between DAP3 expression and responder numbers based on TIDE scores. (E) Predicted immune response and tumor microenvironment characteristics in low and high DAP3 expression groups. (F) Expression levels of immune checkpoint genes in low and high-risk groups. *P<0.05,**P<0.01,***P<0.001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Correlation between DAP3 and immune-related functions in HCC: (A) Immune cell infiltration in low and high DAP3 expression groups based on TIMER scores. (B) Immune cell infiltration in low and high DAP3 expression groups based on CIBERSORT scores. (C) Immune cell infiltration in low and high DAP3 expression groups based on MCP-counter scores. (D) Proportional plot illustrating the relationship between DAP3 expression and responder numbers based on TIDE scores. (E) Predicted immune response and tumor microenvironment characteristics in low and high DAP3 expression groups. (F) Expression levels of immune checkpoint genes in low and high-risk groups. *P<0.05,**P<0.01,***P<0.001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing

    The potential role of DAP3 in HCC genomic alterations: (A) Classification and frequency of gene mutations. (B) Waterfall plot depicting gene mutations in the high-DAP3 expression group. (C) Waterfall plot illustrating gene mutations in the low-DAP3 expression group. (D) DAP3 expression levels and genomic alterations in low versus high DAP3 expression groups. (E) Distribution of copy number variations (CNVs) across different chromosomal regions in the high-DAP3 expression group. (F) Distribution of CNVs across different chromosomal regions in the low-DAP3 expression group. **P<0.01, ***P<0.001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: The potential role of DAP3 in HCC genomic alterations: (A) Classification and frequency of gene mutations. (B) Waterfall plot depicting gene mutations in the high-DAP3 expression group. (C) Waterfall plot illustrating gene mutations in the low-DAP3 expression group. (D) DAP3 expression levels and genomic alterations in low versus high DAP3 expression groups. (E) Distribution of copy number variations (CNVs) across different chromosomal regions in the high-DAP3 expression group. (F) Distribution of CNVs across different chromosomal regions in the low-DAP3 expression group. **P<0.01, ***P<0.001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing

    A single-cell expression atlas and the identification of DAP3 in HCC by scRNA-seq: (A) Distribution of various cell types in hepatocellular carcinoma (HCC). (B) Comparison of cell type distribution in adjacent liver and tumor tissues. (C) Top five marker genes for different cell types. (D) Expression levels of DAP3 across various cell types. (E) Expression and distribution of DAP3 in adjacent liver tissues. (F) Expression and distribution of DAP3 in tumor tissues. (G) Comparison of gene expression levels in different cell types within tumor tissues versus adjacent tissues. (H) Gene expression levels in different cell types during recurrence compared to non-recurrence conditions.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: A single-cell expression atlas and the identification of DAP3 in HCC by scRNA-seq: (A) Distribution of various cell types in hepatocellular carcinoma (HCC). (B) Comparison of cell type distribution in adjacent liver and tumor tissues. (C) Top five marker genes for different cell types. (D) Expression levels of DAP3 across various cell types. (E) Expression and distribution of DAP3 in adjacent liver tissues. (F) Expression and distribution of DAP3 in tumor tissues. (G) Comparison of gene expression levels in different cell types within tumor tissues versus adjacent tissues. (H) Gene expression levels in different cell types during recurrence compared to non-recurrence conditions.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing, Comparison, Marker, Gene Expression

    Increased DAP3 expression was associated with poor prognosis in HCC patients: (A) Relative DAP3 expression levels in HCC tissues as measured by qRT-PCR (n = 71). (B) DAP3 expression analyzed via Western blot in HCC tissues (n = 4). (C) Representative images of DAP3 expression in HCC tissues obtained through immunohistochemical staining (magnification: 40X; scale bar: 100 μm). (D) IHC scores for DAP3 expression. (E) ROC curve analysis of DAP3 expression and AFP value. (F) Overall survival (OS) time compared using Kaplan–Meier analysis. ***P<0.001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Increased DAP3 expression was associated with poor prognosis in HCC patients: (A) Relative DAP3 expression levels in HCC tissues as measured by qRT-PCR (n = 71). (B) DAP3 expression analyzed via Western blot in HCC tissues (n = 4). (C) Representative images of DAP3 expression in HCC tissues obtained through immunohistochemical staining (magnification: 40X; scale bar: 100 μm). (D) IHC scores for DAP3 expression. (E) ROC curve analysis of DAP3 expression and AFP value. (F) Overall survival (OS) time compared using Kaplan–Meier analysis. ***P<0.001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Immunohistochemical staining, Staining

    Correlation of  DAP3  expression with clinicopathological characteristics in HCC patients.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Correlation of DAP3 expression with clinicopathological characteristics in HCC patients.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Expressing

    Univariate and multivariate Cox regression analyses related to overall survival in patients with HCC.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Univariate and multivariate Cox regression analyses related to overall survival in patients with HCC.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques:

    Knockdown of DAP3 inhibited the progression of HCC cells: (A) DAP3 expression levels in normal hepatocytes (LO2) compared to five HCC cell lines. (B) Knockdown efficiency in HCCLM3 cells confirmed by qRT-PCR. (C) Knockdown efficiency in HCCLM3 cells validated by Western blot. (D) CCK-8 assay results in DAP3-knockdown HCCLM3 cells. (E) Colony formation assay conducted in DAP3-knockdown HCCLM3 cells. (F) Number of colonies formed in DAP3-knockdown HCCLM3 cells. (G) Representative images from migration and invasion assays in DAP3-knockdown HCCLM3 cells. (H) Number of migrated or invaded cells in DAP3-knockdown HCCLM3 cells. (I) Apoptosis levels in DAP3-knockdown HCCLM3 cells. (J) Apoptotic rates in DAP3-knockdown HCCLM3 cells. *P<0.05,**P<0.01,***P<0.001,****P<0.0001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Knockdown of DAP3 inhibited the progression of HCC cells: (A) DAP3 expression levels in normal hepatocytes (LO2) compared to five HCC cell lines. (B) Knockdown efficiency in HCCLM3 cells confirmed by qRT-PCR. (C) Knockdown efficiency in HCCLM3 cells validated by Western blot. (D) CCK-8 assay results in DAP3-knockdown HCCLM3 cells. (E) Colony formation assay conducted in DAP3-knockdown HCCLM3 cells. (F) Number of colonies formed in DAP3-knockdown HCCLM3 cells. (G) Representative images from migration and invasion assays in DAP3-knockdown HCCLM3 cells. (H) Number of migrated or invaded cells in DAP3-knockdown HCCLM3 cells. (I) Apoptosis levels in DAP3-knockdown HCCLM3 cells. (J) Apoptotic rates in DAP3-knockdown HCCLM3 cells. *P<0.05,**P<0.01,***P<0.001,****P<0.0001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Knockdown, Expressing, Quantitative RT-PCR, Western Blot, CCK-8 Assay, Colony Assay, Migration

    Overexpression of DAP3 promoted the progression of HCC cells: (A) Overexpression efficiency in SK-Hep1 cells confirmed by qRT-PCR. (B) Overexpression efficiency in SK-Hep1 cells validated by Western blot. (C) CCK-8 assay results in DAP3-overexpressing SK-Hep1 cells. (D) Colony formation assay conducted in DAP3-overexpressing SK-Hep1 cells. (E) Number of colonies formed in DAP3-overexpressing SK-Hep1 cells. (F) Representative images from migration and invasion assays in DAP3-overexpressing SK-Hep1 cells. (G) Number of migrated or invaded cells in DAP3-overexpressing SK-Hep1 cells. (H) Apoptosis levels in DAP3-overexpressing SK-Hep1 cells. (I) Apoptotic rates in DAP3-overexpressing SK-Hep1 cells. (J) Volcano plot shown the co-expressed protein with DAP3 in HCC. (K) Correlation analysis between DAP3, FLAD1, HAX1, and NDUFS2 based on GEPIA datasets. *P<0.05, **P<0.01, ***P<0.001.

    Journal: Frontiers in Immunology

    Article Title: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma

    doi: 10.3389/fimmu.2025.1528853

    Figure Lengend Snippet: Overexpression of DAP3 promoted the progression of HCC cells: (A) Overexpression efficiency in SK-Hep1 cells confirmed by qRT-PCR. (B) Overexpression efficiency in SK-Hep1 cells validated by Western blot. (C) CCK-8 assay results in DAP3-overexpressing SK-Hep1 cells. (D) Colony formation assay conducted in DAP3-overexpressing SK-Hep1 cells. (E) Number of colonies formed in DAP3-overexpressing SK-Hep1 cells. (F) Representative images from migration and invasion assays in DAP3-overexpressing SK-Hep1 cells. (G) Number of migrated or invaded cells in DAP3-overexpressing SK-Hep1 cells. (H) Apoptosis levels in DAP3-overexpressing SK-Hep1 cells. (I) Apoptotic rates in DAP3-overexpressing SK-Hep1 cells. (J) Volcano plot shown the co-expressed protein with DAP3 in HCC. (K) Correlation analysis between DAP3, FLAD1, HAX1, and NDUFS2 based on GEPIA datasets. *P<0.05, **P<0.01, ***P<0.001.

    Article Snippet: The antibodies used for Western blot were as follows: anti-GAPDH antibody (1:20000, Proteintech, China), anti-DAP3 antibody (1:200, Santa Cruz, China), HRP-conjugated-β-actin antibody (1:5000, Proteintech, China) and HRP-conjugated goat anti-mouse IgG antibody (1:1000, Beyotime, China).

    Techniques: Over Expression, Quantitative RT-PCR, Western Blot, CCK-8 Assay, Colony Assay, Migration

    Comparison of the selected phage endolysins.

    Journal: Journal of Xenobiotics

    Article Title: The Unique Capability of Endolysin to Tackle Antibiotic Resistance: Cracking the Barrier

    doi: 10.3390/jox15010019

    Figure Lengend Snippet: Comparison of the selected phage endolysins.

    Article Snippet: Endolysin , 266 , vB_BceM_AP3_0015 , Burkholderia phage AP3 , E. coli, K. pneumoniae, P. aeruginosa, B. cenocepacia, S. enterica, Staphylococcus aureus and S. epidermidis , Both , In vitro , None , YES , ATCC , pEXP5-CT/TOPO , Escherichia coli BL21-AI , pH 3–10 , 10–55 °C , [ ] .

    Techniques: Comparison, Activity Assay, Bacteria, Animal Model, Expressing, Plasmid Preparation, In Vitro